ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Why Research Sites Don't Use EMR As The Source Data Collection Tool

  Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.

• How eConsent Improves The Trial Experience For Patients And Sites

  In part one of this series, the author dives into how electronic consent platforms are simplifying and improving the trial experience for patients and sites.

• Paper COAs In 2026? It's Not "Cheaper," It's Riskier

  Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

• Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC

  Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.

• Hidden Costs Of Data Cleaning: Build Quality At The Source

  Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• OpenClinica EDC: Friendly & Easy to Deploy?

  Find out how OpenClinica stands out in the global EDC landscape through its user-friendly interface, strong integration capabilities, and extensive partnerships.

• Clinical Data Needs Smart Automation Now for a Better AI Future

  AI holds the potential to enhance clinical trial efficiency, but it relies on a foundation of clean data and intelligent automation to be effective.

• The Future Of Clinical Trials Rests On A Unified CTMS Platform

  Discover why a unified CTMS platform is the answer for managing both the clinical trial itself and the data it produces when it comes to poorly integrated clinical trial management systems (CTMS).

• Atlantic Research Group Builds Competitive Advantage With Medrio EDC

  By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.